Novo Nordisk’s Blood Disorder Breakthrough Offers a Lifeline Amid GLP-1 Gloom
Novo Nordisk’s etavopivat succeeds in Phase 3 sickle cell trial, cutting painful crises by 27%. This diversifies its…
The new world disorder reopens the debate on the euro in Sweden
CopenhagenThe Russian invasion of Ukraine precipitated the end of Swedish neutrality with its entry into NATO. Now the…